To establish the efficacy of PPI therapy for ulcer bleeding in the United States, do we need more patients or more PPIs?

American Journal of Gastroenterology

Volumn 101, Issue 9, 2006, Pages 2000-2002

  Leontiadis, Grigoris I ^a   Howden, Colin W ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C19; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE;

CLINICAL TRIAL; DISEASE CONTROL; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; EVIDENCE BASED MEDICINE; GASTROINTESTINAL ENDOSCOPY; HEMOSTASIS; HOSPITALIZATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; META ANALYSIS; MORTALITY; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNITED STATES;

DUODENAL ULCER; ENZYME INHIBITORS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INCIDENCE; PEPTIC ULCER HEMORRHAGE; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; UNITED STATES;

EID: 33748373180     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00786.x     Document Type: Review

References (20)

1. Cook DJ, Guyatt GH, Salena BJ, et al. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis. Gastroenterology 1992;102:139-48.
2. 2 antagonists in acute upper gastrointestinal hemorrhage: Implications of randomized trials. N Engl J Med 1985;313:660-6.
3. 2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther 2002;16:1137-42.
4. Leontiadis GI, McIntyre L, Sharma VK, et al. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane database of systematic reviews 2004, Issue 3. Art. No.: CD002094.pub2. DOI: 10.1002/14651858.CD002094. pub2.
5. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ 2005;330:568-70.
6. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. The cochrane database of systematic reviews 2006; Issue 1. Art. No.: CD002094.pub3. DOI: 1002/14651858.CD002094.pub3.
7. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: Enhanced efficacy of proton pump inhibitor therapy for peptic ulcer bleeding in Asia - A post hoc analysis from the Cochrane Collaboration. Alim Pharmacol Ther 2005;21:1055-61.
8. Jensen DM, Pace SC, Soffer E, et al. Continuous infusion of pantoprazole versus. ranitidine for prevention of ulcer rebleeding: A U.S. multicenter randomized, double-blind study. Am J Gastroenterol 2006;101:1991-9.
9. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343:310-6.
10. Jones DB, Howden CW, Burget DW, et al. Acid suppression in duodenal ulcer. A meta analysis to define optimal dosing with antisecretory drugs. Gut 1987;28:1120-7.
11. Bell NJV, Burget DW, Howden CW, et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992;51(suppl 1):59-67.
12. Howden CW, Jones DB, Peace KE, et al. The treatment of gastric ulcer with antisecretory drugs: Relationship of pharmacological effect to healing rates. Dig Dis Sci 1988;33:619-24.
13. Howden CW, Hunt RH. The relationship between suppression of acidity and gastric ulcer healing rates. Aliment Pharmacol Ther 1990;4:25-33.
14. Green FJ, Kaplan MM, Curtis LE, et al. Effects of acid and pepsin on blood coagulation and platelet aggregation. Apossible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74:38-43.
15. Patchett SE, Enright H, Afdhal N, et al. Clot lysis by gastric juice: An in vitro study. Gut 1989;30:1704-7.
16. Howden CW, Metz DC, Hunt B, et al. Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h. Aliment Pharmacol Ther 2006;23:975-84.
17. Metz DC, Amer F, Hunt B, et al. Lansoprazole regimens that sustain intragastric pH > 6.0: An evaluation of intermittent oral and continuous intravenous infusion dosages. Aliment Pharmacol Ther 2006;23:985-95.
18. van Herwaarden MA, Samson M, van Nispen CHM, et al. The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine. Aliment Pharmacol Ther 1999;13:731-40.
19. Cortes P, Riquelme A, Vial P, et al. Omeprazole boluses increase intragastric pH more effectively in Helicobacter pylori patients with non-variceal upper gastrointestinal bleeding. Gastroenterology 2003;124:A-626.
20. Jensen DM, Savides T, Sitzer M, et al. Demographics, risk factors, and outcomes of peptic ulcer hemorrhage in the United States: Results of a large multicenter study. Gastroenterology 2003;124:A-17.